In Depth
Maceration and the Timing of Intrauterine Death
Richard M. Pauli, M.D., Ph.D.
Maceration is the process of tissue degeneration which
begins to occur as soon as an undelivered infant dies. It
arises secondary to the effects of autolytic enzymes.
Since this process occurs in what is usually a sterile
environment, the changes which arise are unlike those
which occur following other deaths.
There are multiple reasons for trying to estimate the
time of fetal death. Such information is of some
importance to a babys parents; in fact, nearly all
parents desire to know when their baby died. Certainly
differentiation of intrapartum and prepartum deaths is
relevant to the assessment of any methods of intervention
or prevention; intrapartum deaths are less often of fetal
origin and may include instances more amenable to medical
intervention. Estimation of timing of death also may help
in assessing whether a proposed cause of death is
reasonable.
Only occasionally, however, is independent
documentation of the time of fetal death obtained. For
example, it is uncommon to have ultrasonographic
evaluations close enough together to bracket the time of
death accurately. Most often, then, assessing severity of
maceration is the only method available for confirming
when death occurred.
The sequence of macerative changes has been well
described. Within hours after death changes occur in the
epidermal-dermal junction resulting in what usually is
termed skin slippage. If the skin is rubbed
the epidermis will detach from the underlying tissues.
Shortly thereafter, fluid begins to accumulate under the
skin. Bullae (blisters) may develop (which should not be
misinterpreted as being secondary to an abnormality of
development such as epidermolysis bullosa). These bullae
rupture spontaneously or from delivery resulting in
patchy denudation of the skin. Sloughing of skin from
larger and greater number of surfaces indicates that the
interval between death and delivery is longer. With
antenatal death more than a few days prior to delivery
other changes begin to occur including generalized
hypermobility of joints, change in the color of the fetal
skin surfaces to a pale grey-yellow and liquefaction of
internal organs.
Qualitative scales can be generated based upon this
sequence of events. We chose to use a five-grade scale
based primarily on the external characteristics of the
stillborn, since virtually all infants with studies
submitted to WiSSP are clinically assessed and since we
usually could double check the estimates of maceration
using submitted photographs. That scale of severity of
maceration is as follows:
None
Slight -- skin slippage, rare bullae, little (e.g.
scrotum only or single spots of skin loss elsewhere) or
no denudation

Mild -- focal denudation of multiple regions without
other changes
Moderate-- generalized skin maceration/ denudation but
without significant compressive changes Advanced --
compression and/or mummification and/or internal
liquefaction
Examples of each of these are shown in the figures.

In the WiSSP series, the distribution of degree of
maceration in the first 1040 stillborns is:

| None |
16.0% |
| Slight |
11.6% |
| Mild |
17.7% |
| Moderate |
29.4% |
| Advanced |
22.5% |
(with the rest "indeterminate").
Note that intrapartum deaths (babies with no
macerative changes) are quite infrequent, accounting for
only about a sixth of all stillborns.
Given the relevance of severity of maceration to
timing of fetal death, it is a little surprising that no
careful assessment of the absolute relationship (rather
than just the sequence) between macerative changes and
interval since death was attempted until recently. Prior
to then we could only vaguely correlate severity of
maceration and interval since death. A series of articles
(References 1-3) appeared in 1992 which made such
estimation much more precise. David Genest and his
colleagues conducted careful assessments of fetuses in
whom timing of death was well documented. From those
assessments they were able to provide far more specific
information about the absolute timing of external
macerative changes, internal histologic changes and
placental changes. Related to external characteristics
they found that changes occurred somewhat more rapidly
than previously assumed. Six of their measures seem
applicable to the scale used by WiSSP:
| Feature |
Interval between death and delivery |
| Skin desquamation of > or =1 cm |
> or = 6 hours |
| Skin desquamation involving the face, back
and/or abdomen |
> or =12 hours |
| Skin desquamation involving at least 5% of
body surface |
> or = 18 hours |
| Change of skin coloration to tan or brown |
> or = 24 hours |
| Generalized skin desquamation |
> or = 24 hours |
| Mummification |
> or = 14 days |
Note that Genest failed to find any good measures for
intervals between 24 hours and 2 weeks. Nonetheless,
based on these findings we can better estimate the
relationship between our maceration scale and time
interval between death and delivery:
None = intrapartum death
Slight = less than 12 hours between death and delivery
Mild = about 12-24 hours between death and delivery
Moderate = one to a few days between death and
delivery
Advanced = more than a few days between death and
delivery.
The gap between 24 hours and 2 weeks can be filled
using histologic features if they are adequately searched
for. Genest et al. found that the distribution of a
single feature on routine histologic slides allowed for
interval estimates. That feature was loss of nuclear
basophilia (loss of hematoxylin staining of
nucleoproteins of cells) of a particular organ:
Loss of at least 1% of nuclear staining -
| Kidney tubules |
> or = 4 hours |
| Hepatocytes |
> or = 24 hours |
| Inner half of Myocardium |
> or = 24 hours |
| Outer half of Myocardium |
> or = 48 hours |
| Bronchial epithelium |
> or = 96 hours |
Loss of all or virtually all nuclear staining -
| Liver |
> or = 96 hours |
| GI tract |
> or = 1 week |
| Adrenal |
> or = 1 week |
| Tracheal chondrocytes |
> or = 1 week |
| Kidney |
> or = 4 weeks |
We have not routinely included estimates of time
interval between death and delivery in our summaries. We
would be interested in knowing whether inclusion of such
an estimate would be helpful to referring health care
providers.
Further Reading*
1. Genest DR, Williams MA, Greene MF: Estimating the time
of death in stillborn fetuses: I. Histologic evaluation
of fetal organs; and autopsy study of 150 stillborns.
Obstet Gynecol 80:575-584, 1992.
2. Genest DR: Estimating the time of death in
stillborn fetuses: II. Histologic evaluation of the
placenta; a study of 71 stillborns. Obstet Gynecol
80:585-592, 1992.
3. Genest DR, Singer DB: Estimating the time of death
in stillborn fetuses: III. External fetal examination; a
study of 86 stillborns. Obstet Gynecol 80:593-600, 1992.
4. Wigglesworth JS: The macerated stillborn fetus, in
Perinatal Pathology, Philadelphia: Saunders, 1984, pp.
84-92.
*Copies of these and other relevant articles are
available for personal use by request from WiSSP.
|